" class="no-js "lang="en-US"> Holmusk - Medtech Alert
Saturday, June 21, 2025
Holmusk | Pharmtech Focus

Holmusk

About Holmusk

Holmusk

Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases.

Founded in 2015, Holmusk is headquartered in Singapore with offices in North Carolina, New York City, London, Malaysia and Shanghai. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort.

Holmusk’s vision is to build the world’s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools.

Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine.

Related Story

Holmusk Announces Closing of Strategic Investment from Healthcare and Life Science Industry Leaders

December 6 2021

Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]

Holmusk Signs Agreements with UTHealth and The Harris Center

August 18 2021

Holmusk, a leading global data science and health technology company building the world’s largest Real-World […]

Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs

July 7 2021

Otsuka Pharmaceutical Development & Commercialization, Inc. (“Otsuka”), announces today that it has entered a three-year […]

Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK

April 27 2021

Holmusk, a leading global data science and digital health company building the world’s largest Real-World […]